| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/30/1999 | WO1999048923A1 Multivalent ligands which modulate angiogenesis |
| 09/30/1999 | WO1999048922A1 Process for the preparation of thromboplastin from animal tissue |
| 09/30/1999 | WO1999048921A1 Novel mammalian g-protein coupled receptors having extracellular leucine rich repeat regions |
| 09/30/1999 | WO1999048920A1 Novel physiologically active peptides and utilization thereof |
| 09/30/1999 | WO1999048919A1 H.pylori antigen and its use |
| 09/30/1999 | WO1999048918A1 Protease conjugates |
| 09/30/1999 | WO1999048917A2 Formulation having a papilloma virus-specific protein, and the production and use thereof |
| 09/30/1999 | WO1999048916A2 Hypoxia-inducible human genes, proteins, and uses thereof |
| 09/30/1999 | WO1999048915A1 Orphan nuclear receptor |
| 09/30/1999 | WO1999048910A1 Use of inhibitors of mammalian asparaginyl endopeptidase for therapy of autoimmune disease |
| 09/30/1999 | WO1999048905A1 Methods for identifying a risk to ucp2 and ucp3 gene variant-related afflictions and compositions thereof |
| 09/30/1999 | WO1999048904A1 HIGH AFFINITY TGFβ NUCLEIC ACID LIGANDS AND INHIBITORS |
| 09/30/1999 | WO1999048527A1 Apo-2 ligand-anti-her-2 antibody synergism |
| 09/30/1999 | WO1999048523A2 Antagonists of the inflammatory mediator oncostatin m (osm) |
| 09/30/1999 | WO1999048521A1 Sciellin and uses thereof |
| 09/30/1999 | WO1999048518A2 Medicament for preventing or treating papilloma virus-specific tumors |
| 09/30/1999 | WO1999048513A1 Methods and compositions for peptide synthesis |
| 09/30/1999 | WO1999048508A1 Treatment of ulcerative colitis with tropomyosin isoforms and monoclonal antibodies to tropomyosin isoforms |
| 09/30/1999 | WO1999048486A2 Plant cell cyclin genes |
| 09/30/1999 | WO1999048348A1 Helicobacter pylori derived factor which inhibits ena-78 secretion |
| 09/30/1999 | WO1999042478A3 LEPTOSPIRAL OUTER MEMBRANE PROTEIN, LipL32 |
| 09/30/1999 | WO1999041383A8 Antigen library immunization |
| 09/30/1999 | WO1999040211A3 Strawberry fruit promoters for gene expression |
| 09/30/1999 | WO1999040198A3 Identification, production and use of staphylokinase derivatives with reduced immunogenicity and/or reduced clearance |
| 09/30/1999 | WO1999038987A8 METHOD FOR PRODUCING, BY PLANT CELLS, α1-ANTITRYPSIN AND ITS ALLELES, AND PRODUCTS CONTAINING THE RESULTING α1-ANTITRYPSIN |
| 09/30/1999 | WO1999037788A3 Diagnosis and treatment of aur1 and/or aur2 related disorders |
| 09/30/1999 | WO1999037777A3 Differentiation-associated sequences and methods of use therefor |
| 09/30/1999 | WO1999037758A3 Expression of proteolytically-sensitive peptides |
| 09/30/1999 | WO1999036560A3 Viral vectors encoding neurofilament light proteins and their use |
| 09/30/1999 | WO1999035266A3 Human urotensin ii |
| 09/30/1999 | WO1999035246A9 Novel steroid-activated nuclear receptors and uses therefor |
| 09/30/1999 | WO1999032519A9 Novel g protein-coupled receptor |
| 09/30/1999 | WO1999032149A9 GENES FOR MALE ACCESSORY GLAND PROTEINS IN $i(DROSOPHILA MELANOGASTER) |
| 09/30/1999 | WO1999029159A9 Plant senescence-associated genes |
| 09/30/1999 | WO1999025862A9 Chimeric viral packaging signal without gag gene sequences |
| 09/30/1999 | WO1999024581A3 Plant-optimized genes encoding pesticidal toxins |
| 09/30/1999 | WO1999020761A3 Compositions and methods for identifying and testing therapeutics against hsv infection |
| 09/30/1999 | WO1999014327A3 Genes amplified in tumours, antibodies against the proteins coded thereby, and their use in diagnosis and treatment of cancer |
| 09/30/1999 | WO1999013898A9 EC-3, AN INHIBITOR OF α4β1 AND α4β7 INTEGRINS |
| 09/30/1999 | WO1999011791A3 Tumor necrosis factor family receptors and ligands, encoding nucleic acids and related binding agents |
| 09/30/1999 | WO1999001085A3 Autoimmune inner ear disease antigen and diagnostic assay |
| 09/30/1999 | WO1998018824A9 Human tumor necrosis factor receptor-like 2 |
| 09/30/1999 | WO1997047731A3 Suppression of specific classes of soybean seed protein genes |
| 09/30/1999 | DE19813774A1 Parapockenvirus-kodierter vaskulärer Endothelzell Wachstumsfaktor (PPV-VEGF) Parapoxvirus-coded vascular endothelial growth factor (VEGF PPV) |
| 09/30/1999 | DE19813692A1 Cyanophycin synthetase gene useful for producing transgenic plants for food or fodder use or for producing cyanophycin or derivatives, e.g. polyasparate polymers |
| 09/30/1999 | DE19813048A1 Nucleic acids useful for identifying compounds capable of inducing pathogen resistance in plants |
| 09/30/1999 | DE19812714A1 Verfahren zur Herstellung von mineralisierten Kollagenfibrillen und deren Verwendung als Knochenersatzwerkstoff A process for the production of mineralized collagen fibrils and their use as bone substitute material |
| 09/30/1999 | CA2325585A1 Inflammatory mediator antagonists |
| 09/30/1999 | CA2325570A1 Protein expression in floral cells |
| 09/30/1999 | CA2324648A1 Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items |
| 09/30/1999 | CA2324515A1 Plant control genes |
| 09/30/1999 | CA2324506A1 Protease conjugates |
| 09/30/1999 | CA2324494A1 Apo-2 ligand-anti-her-2 antibody synergism |
| 09/30/1999 | CA2324345A1 Human vault rna |
| 09/30/1999 | CA2324230A1 Kinase wee1 fusion protein compositions, nucleotide sequences, expression systems, and methods of use |
| 09/30/1999 | CA2323927A1 Mutations responsible for attenuation in measles virus or human respiratory syncytial virus subgroup b |
| 09/30/1999 | CA2323832A1 Signal transduction protein involved in plant dehiscence |
| 09/30/1999 | CA2323786A1 Methods of cancer diagnosis using a chimeric toxin |
| 09/30/1999 | CA2323640A1 Human calcium-binding proteins |
| 09/30/1999 | CA2323605A1 Protein phosphatase-related molecules |
| 09/30/1999 | CA2323601A1 Casb414: antigen overexpressed in several tumors |
| 09/30/1999 | CA2323573A1 Medicament for preventing or treating papilloma virus-specific tumors |
| 09/30/1999 | CA2323526A1 Formulation having a papilloma virus-specific protein, and the production and use thereof |
| 09/30/1999 | CA2323501A1 Compounds related to pap-1 |
| 09/30/1999 | CA2323063A1 Use of inhibitors of mammalian asparaginyl endopeptidase for therapy of autoimmune disease |
| 09/30/1999 | CA2322843A1 Hypoxia-inducible human genes, proteins, and uses thereof |
| 09/30/1999 | CA2290653A1 Streptococcus sag-a, a structural protein associated with sls activity |
| 09/30/1999 | CA2233725A1 Hemoglobin-hydroxyethyl starch complexes |
| 09/29/1999 | EP0945515A2 Production of proteins using homologous recombination |
| 09/29/1999 | EP0945510A1 STRAIN BELONGING TO THE GENUS $i(BACILLUS) AND INSECTICIDAL PROTEINS |
| 09/29/1999 | EP0945509A2 A gene from Petunia hybrida coding a for transcription factor |
| 09/29/1999 | EP0945508A1 The insect-resistant use of sweet potato sporamin gene and method for controlling pests using the gene |
| 09/29/1999 | EP0945506A1 Novel peptide, novel dna, and novel antibody |
| 09/29/1999 | EP0945505A1 Novel semaphorin gene: semaphorin w |
| 09/29/1999 | EP0945502A1 A mutated subtilisin protease |
| 09/29/1999 | EP0945463A2 Process for the preparation of human leukocyte (alpha) interferon |
| 09/29/1999 | EP0945462A1 Mycrobacterium tuberculosis specific DNA fragment |
| 09/29/1999 | EP0945461A1 Lipopeptides inducing T-cyxtotoxic lymphocytes and their use as vaccines |
| 09/29/1999 | EP0945146A2 Method for making mineralized collagen fibrils and their use as bone replacement material |
| 09/29/1999 | EP0944837A1 Methods and reagents for determining protein s |
| 09/29/1999 | EP0944738A2 Compositions and methods using eukaryotic rad52 |
| 09/29/1999 | EP0944737A1 Representations of bimolecular interactions |
| 09/29/1999 | EP0944734A1 Bacillus strain and antibiotic screening method |
| 09/29/1999 | EP0944728A1 METHODS OF USING THE $i(NIM1) GENE TO CONFER DISEASE RESISTANCE IN PLANTS |
| 09/29/1999 | EP0944726A1 Methods for modulating metabolic pathways of micro-organisms and micro-organisms obtainable by said methods |
| 09/29/1999 | EP0944723A2 Mammalian chemokines |
| 09/29/1999 | EP0944722A2 Pituitary-tumor-transforming-genes, and related products |
| 09/29/1999 | EP0944721A1 Adipocyte-specific differentiation-related protein |
| 09/29/1999 | EP0944720A1 Adaptor protein frs2 and related products and methods |
| 09/29/1999 | EP0944718A2 Tryparedoxin, expression plasmid, process of production, use, test system and pharmaceutical preparation |
| 09/29/1999 | EP0944651A2 Genes amplified in cancer cells |
| 09/29/1999 | EP0944650A1 Antithrombotic peptides derived from fibronectin type ii repeats |
| 09/29/1999 | EP0944649A1 METHYLATED, SmD HOMOLOGOUS PEPTIDES, REACTIVE WITH THE ANTIBODIES FROM SERA OF LIVING BEINGS AFFECTED WITH SYSTEMIC LUPUS ERYTHEMATOSUS |
| 09/29/1999 | EP0944648A1 Glp-1 derivatives |
| 09/29/1999 | EP0944647A1 Submucosa extracts |
| 09/29/1999 | EP0944646A1 Secreted proteins and polynucleotides encoding them |
| 09/29/1999 | EP0944580A2 N-(aryl/heteroaryl) amino acid esters, pharmaceutical compositions, and methods for inhibiting beta-amyloid peptide release and/or its synthesis |
| 09/29/1999 | EP0944392A1 Process for separating alpha-1-proteinase inhibitor from cohn fraction iv 1? +iv 4? paste |
| 09/29/1999 | EP0833842B1 Novel peptides for use in treatment of t-cell mediated cartilage destruction in autoimmune diseases |
| 09/29/1999 | EP0714307B1 Vaccine compositions |